Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Is Viking Therapeutics Stock a Buy on the Dip?

TheMotleyFool

0 0

Is Viking Therapeutics Stock a Buy on the Dip?: https://g.foolcdn.com/editorial/images/779740/u-turn.jpg

Viking Therapeutics (NASDAQ: VKTX) is an anomaly of sorts. Despite another underwhelming year for biotech stocks, the metabolic disease specialist has, so far, delivered a staggering 208% return on capital for shareholders in 2024.

The reason? Investors have flocked to the biotech stock in response to its experimental weight loss therapy, VK2735. This is a peptide GLP-1/GIP dual agonist being trialed in both a subcutaneously injected and an oral dosage form.

Image source: Getty Images.

Source Fool.com